Related Experiment Video
Updated: Dec 29, 2025
Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
Lymphadenectomy in Ovarian Cancer: Is It Still Justified?
Pierluigi Benedetti Panici1, Andrea Giannini2, Margherita Fischetti2
1Department of Maternal and Child Health and Urological Sciences, Umberto I, "Sapienza" University of Rome, Viale del policlinico 155, 0161, Rome, Italy. pierluigi.benedettipanici@uniroma1.it.
Purpose Of Review:
The aim of this review is to determine, in the light of recent evidences, the role of lymphadenectomy in ovarian cancer.
Recent Findings:
The lymphadenectomy in ovarian neoplasms (LION) trial reports no better outcomes and higher complication and mortality rates associated with lymphadenectomy. Even if performed by expert hands, lymphadenectomy has a cost in terms of longer operative time, blood loss, higher rates of transfusions, and intensive unit care. If on the one hand retroperitoneal staging is not correlated to survival benefits both in early and advanced ovarian cancer, on the other hand it is associated with an increased surgery-related morbidity. Surgical treatment of isolated nodal recurrences seems to be feasible and associated with survival benefits.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021